FDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot Study
- PMID: 32108697
- DOI: 10.1097/RLU.0000000000002960
FDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot Study
Abstract
Purpose: Cognitive decline in diseases of the Lewy body spectrum (LBS) is linked to dysfunction/degeneration of the basal forebrain (BF). Assessment of glucose metabolism in the BF by FDG PET is hampered by the small size of the BF and limited spatial resolution of conventional PET. This pilot study tested the feasibility of assessing BF glucose metabolism by high-resolution digital PET (dPET).
Patients and methods: The retrospective study included 12 LBS patients (61-86 years, 5 demented). Whole-brain stereotactic normalization to anatomical standard space was followed by local stereotactic normalization of a 7 × 7 × 7-cm box around the BF to a custom-made 1 × 1 × 1-mm FDG dPET template. FDG uptake was scaled voxelwise to mean FDG uptake in the pons. Scaled FDG uptake in the BF was compared between demented and nondemented LBS patients and tested for correlation with cortical FDG uptake.
Results: Scaled FDG uptake in the BF was significantly lower in demented compared with nondemented patients (1.14 ± 0.09 vs 1.25 ± 0.06, P = 0.031). Brain-wide voxel-based testing for correlations with scaled FDG uptake in the BF revealed a large cluster comprising medial and ventrolateral frontal cortex, anterior cingulate cortex, insular cortex, and striatum as well as smaller clusters in motor cortex and occipital cortex (P < 0.001, uncorrected).
Conclusions: These results suggest that dementia-associated BF degeneration in LBS can be sensitively measured as reduced BF FDG uptake on dPET. More accurate delineation of the BF based on individual high-resolution MRI might be useful to make optimal use of improved spatial resolution of dPET and to correct for possible disease- and age-dependent partial volume effects.
Similar articles
-
Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.Neurology. 2022 Mar 1;98(9):e947-e957. doi: 10.1212/WNL.0000000000013277. Epub 2021 Dec 30. Neurology. 2022. PMID: 34969939 Free PMC article.
-
Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11 C]UCB-J and [18 F]FDG PET Study.Mov Disord. 2023 May;38(5):796-805. doi: 10.1002/mds.29375. Epub 2023 Mar 11. Mov Disord. 2023. PMID: 36905188
-
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.Neurology. 2010 Mar 16;74(11):885-92. doi: 10.1212/WNL.0b013e3181d55f61. Epub 2010 Feb 24. Neurology. 2010. PMID: 20181924
-
Brain fluorodeoxyglucose (FDG) PET in dementia.Ageing Res Rev. 2016 Sep;30:73-84. doi: 10.1016/j.arr.2016.02.003. Epub 2016 Feb 11. Ageing Res Rev. 2016. PMID: 26876244 Review.
-
Positron emission tomography imaging in dementia.Br J Radiol. 2007 Dec;80 Spec No 2:S160-7. doi: 10.1259/bjr/97295129. Br J Radiol. 2007. PMID: 18445746 Review.
Cited by
-
Small lesion depiction and quantification accuracy of oncological 18F-FDG PET/CT with small voxel and Bayesian penalized likelihood reconstruction.EJNMMI Phys. 2022 Mar 26;9(1):23. doi: 10.1186/s40658-022-00451-5. EJNMMI Phys. 2022. PMID: 35348926 Free PMC article.
References
-
- Liu AK, Chang RC, Pearce RK, et al. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Acta Neuropathol. 2015;129:527–540.
-
- Chen XQ, Mobley WC. Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses. Front Neurosci-Switz. 2019;13:446.
-
- Gratwicke JP, Foltynie T. Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson's disease. Brain. 2018;141:7–10.
-
- Ray NJ, Bradburn S, Murgatroyd C, et al. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Brain. 2018;141:165–176.
-
- Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res. 1999;24:321–329.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous